Advertisement
Australia markets close in 15 minutes
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,576.80
    -106.20 (-1.38%)
     
  • AUD/USD

    0.6541
    +0.0017 (+0.27%)
     
  • OIL

    84.00
    +0.43 (+0.51%)
     
  • GOLD

    2,347.50
    +5.00 (+0.21%)
     
  • Bitcoin AUD

    98,684.95
    +450.33 (+0.46%)
     
  • CMC Crypto 200

    1,388.97
    +6.40 (+0.46%)
     
  • AUD/EUR

    0.6096
    +0.0023 (+0.38%)
     
  • AUD/NZD

    1.0965
    +0.0007 (+0.07%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • Hang Seng

    17,658.88
    +374.34 (+2.17%)
     
  • NIKKEI 225

    37,964.03
    +335.55 (+0.89%)
     

Why Shares of Seres Therapeutics Rose More Than 21% on Tuesday

Why Shares of Seres Therapeutics Rose More Than 21% on Tuesday

Shares of Seres Therapeutics (NASDAQ: MCRB) climbed more than 21% on Tuesday. The biotech stock, which closed at $8.82 on Monday, opened at $8.63 on Tuesday, then took off, climbing to a daily high of $10.78 in the afternoon. The move was in direct contrast to the general market trend with both the Dow Jones Industrial Average and S&P 500 index down for the day.